Clicky

AIM ImmunoTech Inc.(AIM) News

Date Title
Nov 6 AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
Oct 17 AIM ImmunoTech Engages Business Development Firm, Azenova, LLC to Catalyze Partnering, Development and Commercialization Efforts for Ampligen® Pipeline Programs
Aug 9 AIM ImmunoTech to Discuss Second Quarter 2023 Financial Results on August 15, 2023, and Host Conference Call and Webcast
Aug 8 AIM ImmunoTech Announces Completion of Enrollment in Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions